Somru BioScience has developed an intelli.b™ platform for comparability testing of Biologics/ Biosimilars at molecular level that meets the intent of the FDA guidance for fingerprint-like analysis.
Read MoreSomru BioScience offers high quality, sensitive and robust off-the-shelf ELISA kits for the measurement of anti-drug antibodies (i.e. both anti-innovator and anti- biosimilar) in biological matrices.
Read MoreBiomarkers have become an integral part of the decision- making process not only in the personalized drug development process, but also in biosimilar and biobetter drug development.
Read More© 2024 Somru BioScience Inc. All Rights Reserved.Terms and Conditions of Sales.